🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

What is new on #lupus treatment? Check out our latest publication: ➡️LLDAS and DORIS endpoints associated with improved outcomes, but infrequent with standard therapy ➡️#anifrolumab demonstrated increased rates of LLDAS & DORIS attainment up to 4 yrs 🔗sciencedirect.com/science/articl…

New evidence on the role of genetic factors on #lupus development ➡️polygenic risk scores (non-HLA) were higher in preclinical autoimmunity, and linked to ANA development ➡️pathways involved ROS, antigenic receptors and cytokines 🔗sciencedirect.com/science/articl…

Interested in tendinopathy? Do not miss our latest publication on histologic analysis ➡️BonAIr score: quantitative, accesible and objective tool ➡️correlated with cellular and transcriptomic analysis ➡️applicable in translational studies 🔗sciencedirect.com/science/articl…

Interested in #osteoarthritis? Check out our recent publication on #deeplearning & #multiomics ➡️3 clusters based on plasma, synovial fluid and urine analyses ➡️different pathways predominated in each cluster ➡️improved clinical response performance sciencedirect.com/science/articl…

Starting the first day of the EULAR 2025 Congress learning some traditions of Barcelona's culture and its transfer to the multidisciplinary healthcare teams in Rheumatology #EULAR2025

📍Foot OA affects 1 in 6 adults >50 and is often disabling. 🩺 Clinical ID is easier for 1st MTP than midfoot OA. 💉 Hyaluronan no better than saline. 👟 Prefab orthoses = rocker soles (but better adherence). Take-home messages from Hylton Menz at #EULAR2025

🫁screening of progressive SSc-ILD? ➡️worsening on HRCT detects the most progressors ➡️HRCT scanning is the strongest predictor for reduced mortality ➡️yearly HRCT recommended, esp in high risk patients #EULAR2025 Blaž Burja

Yesterday, we could learn the added value of including stakeholders when developing non-pharmacological interventions for people with rheumatic and muskuloskeletal diseases #EULAR2025

🧠 HPR Move Together: Moving Science into Practice 📍Walkway Hall 6 & 7 – Upper Floor 🗓️ June 12 | 12:15–13:15 🗓️ June 13 | 12:15–13:15 🗓️ June 14 | 10:30–11:30 Let’s move science into action! #EULAR2025 Rafa Prieto

#EULAR2025 Real world data from Brazil on the combination of #MTX and #Leflunomide. 🚫NOT more liver fibrosis 🚫NOT more toxicity Even less hospitalizations Slightly higher ALT levels Would you use it? 🤔 OP0195 Posted by Maria Sokolova, MD PhD

⚡️New insights into post-translational modifications from #EULAR2025! ⭐️#NET formation is involved in #carbamylation. Carbamylated histone H3 activates TLR4, possibly promoting osteoclastogenesis providing potential mechanism for bone erosions OP0149 Posted by Maria Sokolova, MD PhD

💡How to manage Fibromyalgia? Some take-home messages learnt during the #EULAR2025 📖 Advocacy ⚠️ Overcoming the fear 📲 Using the power of digital health 🏃‍♀️Physical exercise Posted by Rafa Prieto

Excellent talk from Dr. Jessica Manson at #EULAR2025 on the treatment of macrophage activation syndrome and why we should call it #HLH (like everyone else) ⚠️escalate early ⚠️beware of tachycardia ⚠️collaboration is key Posted by Maria Sokolova, MD PhD

#EULAR2025 WIN in large vessel vasculitis. ⚠️up to 30% #PMR patients have subclinical #GCA which is associated with: ⚠️older age ⬆️ morning stiffness ⬆️hip involvement If you start with ⬇️ than 20 mg pred in subclin. GCA-> 100% relapse risk! Posted by Maria Sokolova, MD PhD

❓How to improve adherence during the transition from paediatric to adult care? 🔝A great session including in the same session the voice of patients, HPRs and rheumatologists, supported by Fer Estevez-Lopez and Loreto Carmona as chairs. #EULAR2025 Rafa Prieto

A rarely discussed topic of #rheumatoid vasculitis - a great talk from Dr. Makol from the Mayo Clinic at #EULAR2025 ⭐️still very high mortality! ⭐️suspect in smn with constitutional symptoms, low complement (C3!) and ⬆️APR ⭐️RTX emerging as a treatment option By Maria Sokolova, MD PhD

💉Digital ulcers in SSc ➡️selexipag (prostacyclin receptor agonist) showed superior results in treating DU in SSc as compared to iloprost ➡️off-label use in retrospective multicentre italian study ➡️further trials needed to confirm promising results #EULAR2025 Blaž Burja

Great session yesterday on #DISH with a talk from Nelly ZIADE 🍀. Even Ramses might have had it! It was very insightful also to learn about the role of comirbidities, especially #diabetes! #EULAR2025 Posted by Maria Sokolova, MD PhD

👋🏼We say goodbye to the #EULAR2025 Congress with the Highlights session, summarising all the amazing work of this edition. ⏭️ Looking forward to seeing you in London for the #EULAR2026. Rafa Prieto

EULAR highlights🔵 ➡️long-term follow up data from the ARIAA study: 6months treatment intervention w Abatacept delays progression to RA for up to 4 years in ACPA+ patients w artralgia! #EULA25 Blaž Burja